Talking about the "delivery method" for a vaccination that doesn't yet exist is rather extraordinary.
Whether it be by traditional needle and syringe or via the potential in a Nanopatch, the reality is the most important part - the "actual vaccine" doesn't yet exist. As another poster stated (chips) "feels like putting the cart well and ... ... ..."
It's uncomfortable that so many assume the vaccine is a done deal, whilst ignoring all those other entities that have trialled and failed before it.
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-47
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.76 | $13.70 | $346.5K | 24.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 594 | $14.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.83 | 65 | 2 |
View Market Depth
| Last trade - 15.59pm 12/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |